|
|||||
       |
Lymphocyte (National Cancer Institute) The French pharmaceutical company Sanofi and Glenmark Pharmaceuticals Ltd. in Mumbai, India have signed an agreement for development and commercialization of GBR500, a monoclonal antibody to treat chronic autoimmune disorders. The deal is expected to close next month following required regulatory steps. GBR500, developed by Glenmark, targets receptors that . . . → Read More: Sanofi, Glenmark Sign Autoimmune Antibody License Deal  One comment - (Comments are closed)  Intellectual property, Joint ventures/collaborations  Asia, biomedical, biotechnology, Europe, India, licensing, life sciences, pharmaceuticals (Hodder & Stoughton) Review: Geek Nation by Angela Saini. Hodder & Stoughton (3 Mar 2011). Science writer Angela Saini describes the rise of science and engineering in India in her new book Geek Nation. But if you’re looking for a triumphant . . . → Read More: One Nation, Under Geeks 2 comments - (Comments are closed) Business conditions, Hiring/layoffs, Intellectual property, Regulations agriculture, biomedical, computer science, economics, engineering, India, life sciences, pharmaceuticals, physical sciences, university (U.S. Mint) The volume of venture deals for companies in the U.S., Europe, Canada, Israel, China, and India jumped 20 percent to $9.8 billion in the first quarter of 2011 compared to the same quarter in 2010. However, the number of deals worldwide declined 7 percent in the first quarter, to 967. The . . . → Read More: Global Venture Capital Volume Up in Q1, Deal Number Down 2 comments - (Comments are closed) Finance Asia, Canada, China, economics, entrepreneurs, equity, Europe, India, investment, venture capital (Research.gov) InhibOx Ltd. in Oxford, U.K. and COSMIC Discoveries in Hyderabad, India, signed a partnership to offer drug discovery services combining their computational, medicinal, and synthetic chemistry capabilities. Both companies are spin-off enterprises of academic or research institutions — Oxford University and the Institute of Life Sciences, respectively. InhibOx provides computational drug discovery . . . → Read More: U.K., Indian Spin Offs to Partner on Drug Discovery Comments are closed Joint ventures/collaborations Asia, biotechnology, chemistry, computer science, Europe, India, life sciences, pharmaceuticals, U.K., university Cynthia Koenig (Univ. of Michigan) Cynthia Koenig, a business school graduate student at University of Michigan in Ann Arbor, created a rolling water barrel and started an enterprise to distribute the device in developing countries. Koenig plans to pilot test the device, called the WaterWheel, in India. The WaterWheel is a 20-gallon rolling . . . → Read More: Grad Student Creates, Markets Rural Water Conveyance Device Comments are closed Joint ventures/collaborations, New products Asia, engineering, entrepreneurs, India, manufacturing, university, water (Investor.gov) The World Intellectual Property Organization (WIPO) reports today that the number of patent filings under WIPO’s Patent Cooperation Treaty (PCT) increased in 2010, with the largest percentage gains recorded in Asia. Provisional data for 2010 indicate that 162,900 international patent applications were filed in 2010 compared to the 155,398 applications filed in . . . → Read More: Asian Patents Jump in 2010, Decline in U.S., Mixed in Europe One comment - (Comments are closed) Intellectual property Asia, Canada, China, Europe, India, patent H1N1 virus (U.S. Centers for Disease Control) Bharat Biotech in Hyderabad, India said today it developed India’s first cell-culture H1N1 swine flu vaccine. The company believes it is the only developing world flu vaccine to be manufactured in cell culture, a faster and more advanced manufacturing process, instead of eggs. Traditional egg-based flu . . . → Read More: Indian Biotech Develops Cell-Culture H1N1 Vaccine |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.